Can serum tenascin-c be used as a marker of inflammation in patients with dilated cardiomyopathy?  by Kotby, Alyaa A. et al.
Association of circulating endothelial cells with ﬂow mediated vasodila-
tion and disease activity in patients with systemic lupus erythematosus
Rania Gaber, Mai Salama, Mervat El Sergany, Elham Kassem, Hanan
El Saadany, Nesreen A. Kotb
Department of Cardiology, Tanta University, Egypt, Department of
Rheumatology, Tanta University, Egypt, Department of Rehabilita-
tion and Internal Medicine, Tanta University, Egypt.
Objectives: The aim of this study was to determine the correlation
between CEC count and endothelial function, disease activity, and
organ involvement in patients with SLE.
Background: Premature atherosclerosis in patients with systemic lupus
erythematosus (SLE) is not explained by traditional risk factors. Circu-
lating endothelial cells (CEC) have been identiﬁed as a surrogate mar-
ker of endothelial dysfunction
Methods: The present study included 30 premenopausal women
with SLE and 20 age and sex matched healthy controls (HC).
Endothelial function was studied by ﬂow mediated vasodilation
(FMD%) in the brachial artery. Serum levels of VCAM-1,
ICAM-1 were measured.
Results: >FMD% was lower in patients with SLE than HC
(3.5 ± 0.4 vs 9.7 ± 3.2, p< 0.001). CEC count was signiﬁcantly ele-
vated in patients with SLE compared to HC (38 ± 18 vs 7 ± 3,
p< 0.001). CEC count correlated positively with systemic lupus activ-
ity score (r= 0.97), and negatively with FMD% (r= 0.94). Serum
levels of VCAM-1 and ICAM-1 were signiﬁcantly elevated in patients
with SLE compared to HC (p< 0.001). There was a signiﬁcant corre-
lation between CEC count and vasculitic skin lesions (p< 0.01), renal
involvement (p< 0.01), and VCAM-1 levels (p< 0.001).
Conclusion: CEC is associated with endothelial dysfunction, disease
activity and increased VCAM-1 levels in patients with SLE. These ﬁnd-
ings suggest a potential role of CEC in the pathophysiology of cardio-
vascular disease in these patients.
http://dx.doi.org/10.1016/j.ehj.2013.12.008
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Introduction: Tenascin-C (TN-C), an extracellular matrix glycopro-
tein, is speciﬁcally expressed at high levels during embryonic devel-
opment, but not in the adult heart. TN-C reappears at sites of
inﬂammatory tissue remodeling or wound healing under various
pathologic conditions, such as acute myocardial infarction, acute
myocarditis,and some cases of cardiomyopathy. Therefore, the
expression of TN-C might be useful for detecting the clinical char-
acteristics of, and ventricular remodeling in, dilated cardiomyopa-
thy (DCM).
Objectives: To evaluate the role of TN-C as a sensitive marker for
active inﬂammation in children with newly onset DCM
Methods: This case controlled study included 24 patients aged
from 6 to 72 months with a mean age 45.19 ± 11.03 compared
to 20 age and sex matched healthy children. The subjects were
divided into 3 groups. Group 1: included twelve patients with
acute onset DCM, (less than 6 months duration) ,Group 2:
included twelve patients with established chronic DCM, (more
than 6 months duration) and Group 3: twenty (20) healthy age
and sex matched children served as control group: all studied
patients were subjected to full medical history ,thorough clinical
examination.
Investigations included: Serum Tenascin-C , chest X-ray and echocar-
diography using conventional parameters as M-mode, 2D, CW Dopp-
ler and 2D speckle tracking technique.
Results: The 2D Speckle Tracking data showed that the patients
group had lower Global peak Strain Longitudinal Apical long
axis( G SL ap lax), G peak SL apical 4 chamber(a4c), G peak
SL apical 2 chamber(a2c) and G peak SL average with highly sta-
tistical signiﬁcant diﬀerence using T-test. Moreover the global echoc-
ariographic assessment showed that acute cases had lower G peak SL
ap lax, G peak SL ap4c, G peak SL a2c, G peak SL avg, than the
chronic cases with a highly statistically signiﬁcant diﬀerence
(P< 0.001). These data conﬁrm furthermore the global aﬀection of
the acute DCM cases than the chronic cases.Our study showed highly
signiﬁcant statistical elevation of serum Tenascin-c among DCM
patients than in controls (P value <0.001). It also showed that acute
cases had statistically signiﬁcant higher serum levels of Tenascin-c than
chronic cases (P value <0.001). This indicates that serum Tenascin-C
level is elevated in cases of acute dilated cardiomyopathy and is
decreased signiﬁcantly in chronic DCM. And showed that circulating
tenascin-C is generally associated with the severity of left ventricular
dysfunction.
Conclusions: Serum-Tenascin Level was signiﬁcantly increased in
patients with idiopathic dilated cardiomyopathies. This increase was
noted in acute and chronic cases, with signiﬁcant diﬀerence between
both being higher in the acute cases, and associated with the severity
of heart failure and the LV dysfunction as detected by 2D speckle
tracking echocardiography.
http://dx.doi.org/10.1016/j.ehj.2013.12.009
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Objectives: Many techniques have been developed to address
the partial anomalous pulmonary venous drainage into the
superior vena cava with or without sinus venosus atrial sep-
tal defect.
The morphology of this anomaly is responsible for the possible sur-
gical complications including sinus node dysfunction, systemic and/or
pulmonary venous channels obstruction.
Since early 2010, we started to slowly adopt the vertical trans-caval
incision for the correction of this anomaly. Here, we present our early
experience in Alexandria University with six patients operated using
this approach.
Methods: Between April 2010 and April 2011, six patients, aged
between 7 and 35 years, were addressed using one patch of Gluterald-
hyde prepared autologus pericardium, after vertical superior vena
caval incision at the mouth of the anomalous pulmonary veins. Two
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